nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CA2—esophageal cancer	0.684	1	CbGaD
Indapamide—KCNE1—bronchus—esophageal cancer	0.00576	0.114	CbGeAlD
Indapamide—KCNQ1—neck—esophageal cancer	0.00394	0.0781	CbGeAlD
Indapamide—KCNE1—lung—esophageal cancer	0.00371	0.0735	CbGeAlD
Indapamide—KCNQ1—bronchus—esophageal cancer	0.00264	0.0523	CbGeAlD
Indapamide—CA7—trachea—esophageal cancer	0.00261	0.0516	CbGeAlD
Indapamide—CA2—exocrine gland—esophageal cancer	0.00226	0.0447	CbGeAlD
Indapamide—CA7—digestive system—esophageal cancer	0.00224	0.0444	CbGeAlD
Indapamide—KCNQ1—digestive system—esophageal cancer	0.00204	0.0404	CbGeAlD
Indapamide—Furosemide—CA1—esophageal cancer	0.00201	0.264	CrCbGaD
Indapamide—CA9—digestive system—esophageal cancer	0.00197	0.039	CbGeAlD
Indapamide—SLC12A3—lung—esophageal cancer	0.00183	0.0363	CbGeAlD
Indapamide—CA4—neck—esophageal cancer	0.00174	0.0345	CbGeAlD
Indapamide—KCNQ1—lung—esophageal cancer	0.00171	0.0337	CbGeAlD
Indapamide—CA12—trachea—esophageal cancer	0.00169	0.0335	CbGeAlD
Indapamide—Furosemide—CA2—esophageal cancer	0.00152	0.2	CrCbGaD
Indapamide—Chlorthalidone—CA1—esophageal cancer	0.00149	0.196	CrCbGaD
Indapamide—CA12—digestive system—esophageal cancer	0.00146	0.0288	CbGeAlD
Indapamide—CA2—neck—esophageal cancer	0.00144	0.0286	CbGeAlD
Indapamide—CA12—lung—esophageal cancer	0.00122	0.0241	CbGeAlD
Indapamide—KCNQ1—lymph node—esophageal cancer	0.00117	0.0231	CbGeAlD
Indapamide—Chlorthalidone—CA2—esophageal cancer	0.00113	0.148	CrCbGaD
Indapamide—Furosemide—ABCC2—esophageal cancer	0.00111	0.145	CrCbGaD
Indapamide—CA5B—lung—esophageal cancer	0.00109	0.0216	CbGeAlD
Indapamide—CA4—trachea—esophageal cancer	0.00105	0.0207	CbGeAlD
Indapamide—CA2—epithelium—esophageal cancer	0.000983	0.0195	CbGeAlD
Indapamide—CA2—bronchus—esophageal cancer	0.000968	0.0192	CbGeAlD
Indapamide—CA2—smooth muscle tissue—esophageal cancer	0.000947	0.0187	CbGeAlD
Indapamide—CA4—digestive system—esophageal cancer	0.000902	0.0178	CbGeAlD
Indapamide—CA2—trachea—esophageal cancer	0.000869	0.0172	CbGeAlD
Indapamide—CA4—lung—esophageal cancer	0.000753	0.0149	CbGeAlD
Indapamide—CA2—digestive system—esophageal cancer	0.000748	0.0148	CbGeAlD
Indapamide—CA5B—lymph node—esophageal cancer	0.000746	0.0148	CbGeAlD
Indapamide—CA2—lung—esophageal cancer	0.000624	0.0124	CbGeAlD
Indapamide—CA4—lymph node—esophageal cancer	0.000515	0.0102	CbGeAlD
Indapamide—CYP3A4—digestive system—esophageal cancer	0.000482	0.00955	CbGeAlD
Indapamide—CA2—lymph node—esophageal cancer	0.000427	0.00845	CbGeAlD
Indapamide—Renal failure—Cisplatin—esophageal cancer	0.00042	0.0039	CcSEcCtD
Indapamide—Vaginal inflammation—Methotrexate—esophageal cancer	0.000419	0.00389	CcSEcCtD
Indapamide—Lethargy—Capecitabine—esophageal cancer	0.000417	0.00387	CcSEcCtD
Indapamide—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000417	0.00387	CcSEcCtD
Indapamide—Stomatitis—Cisplatin—esophageal cancer	0.000417	0.00387	CcSEcCtD
Indapamide—Conjunctivitis—Cisplatin—esophageal cancer	0.000415	0.00386	CcSEcCtD
Indapamide—Hyponatraemia—Capecitabine—esophageal cancer	0.00041	0.00381	CcSEcCtD
Indapamide—Cystitis noninfective—Methotrexate—esophageal cancer	0.000409	0.0038	CcSEcCtD
Indapamide—Osteoarthritis—Capecitabine—esophageal cancer	0.000409	0.0038	CcSEcCtD
Indapamide—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000405	0.00377	CcSEcCtD
Indapamide—Cystitis—Methotrexate—esophageal cancer	0.000405	0.00376	CcSEcCtD
Indapamide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000404	0.00375	CcSEcCtD
Indapamide—Migraine—Capecitabine—esophageal cancer	0.000402	0.00374	CcSEcCtD
Indapamide—Vaginal infection—Methotrexate—esophageal cancer	0.000396	0.00367	CcSEcCtD
Indapamide—Face oedema—Capecitabine—esophageal cancer	0.000395	0.00366	CcSEcCtD
Indapamide—Aplastic anaemia—Methotrexate—esophageal cancer	0.000394	0.00365	CcSEcCtD
Indapamide—Irritability—Capecitabine—esophageal cancer	0.00039	0.00362	CcSEcCtD
Indapamide—Ataxia—Capecitabine—esophageal cancer	0.000384	0.00357	CcSEcCtD
Indapamide—Dehydration—Capecitabine—esophageal cancer	0.00038	0.00353	CcSEcCtD
Indapamide—Ecchymosis—Methotrexate—esophageal cancer	0.000379	0.00352	CcSEcCtD
Indapamide—Bladder pain—Methotrexate—esophageal cancer	0.000379	0.00352	CcSEcCtD
Indapamide—Urine output increased—Methotrexate—esophageal cancer	0.000379	0.00352	CcSEcCtD
Indapamide—Urinary tract disorder—Cisplatin—esophageal cancer	0.000379	0.00352	CcSEcCtD
Indapamide—Liver function test abnormal—Capecitabine—esophageal cancer	0.000377	0.0035	CcSEcCtD
Indapamide—Urethral disorder—Cisplatin—esophageal cancer	0.000376	0.00349	CcSEcCtD
Indapamide—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000373	0.00347	CcSEcCtD
Indapamide—Abdominal pain upper—Capecitabine—esophageal cancer	0.000373	0.00347	CcSEcCtD
Indapamide—Hypokalaemia—Capecitabine—esophageal cancer	0.000372	0.00345	CcSEcCtD
Indapamide—Visual impairment—Cisplatin—esophageal cancer	0.00037	0.00343	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000368	0.00342	CcSEcCtD
Indapamide—Nasopharyngitis—Capecitabine—esophageal cancer	0.000366	0.00339	CcSEcCtD
Indapamide—Bumetanide—PTGS2—esophageal cancer	0.000363	0.0475	CrCbGaD
Indapamide—Gastritis—Capecitabine—esophageal cancer	0.000362	0.00336	CcSEcCtD
Indapamide—Muscular weakness—Capecitabine—esophageal cancer	0.00036	0.00335	CcSEcCtD
Indapamide—Tinnitus—Cisplatin—esophageal cancer	0.000358	0.00332	CcSEcCtD
Indapamide—Flushing—Cisplatin—esophageal cancer	0.000356	0.00331	CcSEcCtD
Indapamide—Cardiac disorder—Cisplatin—esophageal cancer	0.000356	0.00331	CcSEcCtD
Indapamide—Influenza—Capecitabine—esophageal cancer	0.000353	0.00328	CcSEcCtD
Indapamide—Asthma—Capecitabine—esophageal cancer	0.000353	0.00328	CcSEcCtD
Indapamide—Dysphagia—Capecitabine—esophageal cancer	0.000353	0.00328	CcSEcCtD
Indapamide—Diabetes mellitus—Methotrexate—esophageal cancer	0.00035	0.00325	CcSEcCtD
Indapamide—Photosensitivity—Methotrexate—esophageal cancer	0.000347	0.00322	CcSEcCtD
Indapamide—Polyuria—Methotrexate—esophageal cancer	0.000347	0.00322	CcSEcCtD
Indapamide—Angina pectoris—Capecitabine—esophageal cancer	0.000344	0.0032	CcSEcCtD
Indapamide—Arrhythmia—Cisplatin—esophageal cancer	0.000343	0.00318	CcSEcCtD
Indapamide—Bronchitis—Capecitabine—esophageal cancer	0.00034	0.00315	CcSEcCtD
Indapamide—Hepatic failure—Methotrexate—esophageal cancer	0.000339	0.00314	CcSEcCtD
Indapamide—Malnutrition—Cisplatin—esophageal cancer	0.000334	0.0031	CcSEcCtD
Indapamide—Erythema—Cisplatin—esophageal cancer	0.000334	0.0031	CcSEcCtD
Indapamide—Dysuria—Capecitabine—esophageal cancer	0.00033	0.00307	CcSEcCtD
Indapamide—Flatulence—Cisplatin—esophageal cancer	0.000329	0.00306	CcSEcCtD
Indapamide—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000322	0.00299	CcSEcCtD
Indapamide—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000322	0.00299	CcSEcCtD
Indapamide—Visual disturbance—Methotrexate—esophageal cancer	0.000321	0.00298	CcSEcCtD
Indapamide—Muscle spasms—Cisplatin—esophageal cancer	0.000321	0.00298	CcSEcCtD
Indapamide—Weight decreased—Capecitabine—esophageal cancer	0.00032	0.00297	CcSEcCtD
Indapamide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000319	0.00296	CcSEcCtD
Indapamide—Pneumonia—Capecitabine—esophageal cancer	0.000317	0.00294	CcSEcCtD
Indapamide—Vision blurred—Cisplatin—esophageal cancer	0.000315	0.00292	CcSEcCtD
Indapamide—Depression—Capecitabine—esophageal cancer	0.000314	0.00292	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000312	0.0029	CcSEcCtD
Indapamide—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000311	0.00288	CcSEcCtD
Indapamide—Lethargy—Methotrexate—esophageal cancer	0.000311	0.00288	CcSEcCtD
Indapamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.00031	0.00288	CcSEcCtD
Indapamide—Renal failure—Capecitabine—esophageal cancer	0.00031	0.00288	CcSEcCtD
Indapamide—Anaemia—Cisplatin—esophageal cancer	0.000309	0.00287	CcSEcCtD
Indapamide—Jaundice—Capecitabine—esophageal cancer	0.000307	0.00285	CcSEcCtD
Indapamide—Stomatitis—Capecitabine—esophageal cancer	0.000307	0.00285	CcSEcCtD
Indapamide—Conjunctivitis—Capecitabine—esophageal cancer	0.000306	0.00284	CcSEcCtD
Indapamide—Urinary tract infection—Capecitabine—esophageal cancer	0.000306	0.00284	CcSEcCtD
Indapamide—Osteoarthritis—Methotrexate—esophageal cancer	0.000304	0.00283	CcSEcCtD
Indapamide—Malaise—Cisplatin—esophageal cancer	0.000301	0.0028	CcSEcCtD
Indapamide—Leukopenia—Cisplatin—esophageal cancer	0.000299	0.00278	CcSEcCtD
Indapamide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000298	0.00277	CcSEcCtD
Indapamide—Agranulocytosis—Capecitabine—esophageal cancer	0.000294	0.00273	CcSEcCtD
Indapamide—Irritability—Methotrexate—esophageal cancer	0.00029	0.0027	CcSEcCtD
Indapamide—Ataxia—Methotrexate—esophageal cancer	0.000286	0.00266	CcSEcCtD
Indapamide—Myalgia—Cisplatin—esophageal cancer	0.000284	0.00264	CcSEcCtD
Indapamide—Rhinitis—Capecitabine—esophageal cancer	0.000283	0.00263	CcSEcCtD
Indapamide—Anxiety—Cisplatin—esophageal cancer	0.000283	0.00263	CcSEcCtD
Indapamide—Hepatitis—Capecitabine—esophageal cancer	0.000283	0.00263	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000282	0.00262	CcSEcCtD
Indapamide—Hypoaesthesia—Capecitabine—esophageal cancer	0.000281	0.00261	CcSEcCtD
Indapamide—Liver function test abnormal—Methotrexate—esophageal cancer	0.000281	0.00261	CcSEcCtD
Indapamide—Discomfort—Cisplatin—esophageal cancer	0.000281	0.00261	CcSEcCtD
Indapamide—Pharyngitis—Capecitabine—esophageal cancer	0.000281	0.00261	CcSEcCtD
Indapamide—Urinary tract disorder—Capecitabine—esophageal cancer	0.000279	0.00259	CcSEcCtD
Indapamide—Oedema peripheral—Capecitabine—esophageal cancer	0.000279	0.00259	CcSEcCtD
Indapamide—Urethral disorder—Capecitabine—esophageal cancer	0.000277	0.00257	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000274	0.00254	CcSEcCtD
Indapamide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000273	0.00253	CcSEcCtD
Indapamide—Oedema—Cisplatin—esophageal cancer	0.000273	0.00253	CcSEcCtD
Indapamide—Visual impairment—Capecitabine—esophageal cancer	0.000272	0.00253	CcSEcCtD
Indapamide—Infection—Cisplatin—esophageal cancer	0.000271	0.00251	CcSEcCtD
Indapamide—Erythema multiforme—Capecitabine—esophageal cancer	0.000267	0.00248	CcSEcCtD
Indapamide—Nervous system disorder—Cisplatin—esophageal cancer	0.000267	0.00248	CcSEcCtD
Indapamide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000267	0.00248	CcSEcCtD
Indapamide—Tachycardia—Cisplatin—esophageal cancer	0.000266	0.00247	CcSEcCtD
Indapamide—Skin disorder—Cisplatin—esophageal cancer	0.000265	0.00246	CcSEcCtD
Indapamide—Tinnitus—Capecitabine—esophageal cancer	0.000264	0.00245	CcSEcCtD
Indapamide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000263	0.00245	CcSEcCtD
Indapamide—Asthma—Methotrexate—esophageal cancer	0.000263	0.00244	CcSEcCtD
Indapamide—Flushing—Capecitabine—esophageal cancer	0.000262	0.00244	CcSEcCtD
Indapamide—Cardiac disorder—Capecitabine—esophageal cancer	0.000262	0.00244	CcSEcCtD
Indapamide—Anorexia—Cisplatin—esophageal cancer	0.00026	0.00241	CcSEcCtD
Indapamide—Pancreatitis—Methotrexate—esophageal cancer	0.000258	0.00239	CcSEcCtD
Indapamide—Hypotension—Cisplatin—esophageal cancer	0.000255	0.00236	CcSEcCtD
Indapamide—Arrhythmia—Capecitabine—esophageal cancer	0.000253	0.00235	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000248	0.00231	CcSEcCtD
Indapamide—Erythema—Capecitabine—esophageal cancer	0.000246	0.00229	CcSEcCtD
Indapamide—Malnutrition—Capecitabine—esophageal cancer	0.000246	0.00229	CcSEcCtD
Indapamide—Dysuria—Methotrexate—esophageal cancer	0.000246	0.00228	CcSEcCtD
Indapamide—Paraesthesia—Cisplatin—esophageal cancer	0.000245	0.00227	CcSEcCtD
Indapamide—Dyspnoea—Cisplatin—esophageal cancer	0.000243	0.00226	CcSEcCtD
Indapamide—Flatulence—Capecitabine—esophageal cancer	0.000243	0.00225	CcSEcCtD
Indapamide—Erectile dysfunction—Methotrexate—esophageal cancer	0.000242	0.00225	CcSEcCtD
Indapamide—Dysgeusia—Capecitabine—esophageal cancer	0.000241	0.00224	CcSEcCtD
Indapamide—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00024	0.00223	CcSEcCtD
Indapamide—Back pain—Capecitabine—esophageal cancer	0.000238	0.00221	CcSEcCtD
Indapamide—Decreased appetite—Cisplatin—esophageal cancer	0.000237	0.0022	CcSEcCtD
Indapamide—Muscle spasms—Capecitabine—esophageal cancer	0.000237	0.0022	CcSEcCtD
Indapamide—Pneumonia—Methotrexate—esophageal cancer	0.000236	0.00219	CcSEcCtD
Indapamide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000235	0.00218	CcSEcCtD
Indapamide—Drowsiness—Methotrexate—esophageal cancer	0.000234	0.00218	CcSEcCtD
Indapamide—Depression—Methotrexate—esophageal cancer	0.000234	0.00217	CcSEcCtD
Indapamide—Pain—Cisplatin—esophageal cancer	0.000233	0.00216	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000232	0.00216	CcSEcCtD
Indapamide—Vision blurred—Capecitabine—esophageal cancer	0.000232	0.00215	CcSEcCtD
Indapamide—Renal failure—Methotrexate—esophageal cancer	0.00023	0.00214	CcSEcCtD
Indapamide—Stomatitis—Methotrexate—esophageal cancer	0.000229	0.00212	CcSEcCtD
Indapamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000228	0.00212	CcSEcCtD
Indapamide—Conjunctivitis—Methotrexate—esophageal cancer	0.000228	0.00212	CcSEcCtD
Indapamide—Anaemia—Capecitabine—esophageal cancer	0.000228	0.00211	CcSEcCtD
Indapamide—Sweating—Methotrexate—esophageal cancer	0.000225	0.00209	CcSEcCtD
Indapamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000225	0.00209	CcSEcCtD
Indapamide—Malaise—Capecitabine—esophageal cancer	0.000222	0.00206	CcSEcCtD
Indapamide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000222	0.00206	CcSEcCtD
Indapamide—Vertigo—Capecitabine—esophageal cancer	0.000221	0.00205	CcSEcCtD
Indapamide—Syncope—Capecitabine—esophageal cancer	0.000221	0.00205	CcSEcCtD
Indapamide—Leukopenia—Capecitabine—esophageal cancer	0.00022	0.00205	CcSEcCtD
Indapamide—Agranulocytosis—Methotrexate—esophageal cancer	0.000219	0.00203	CcSEcCtD
Indapamide—Palpitations—Capecitabine—esophageal cancer	0.000218	0.00202	CcSEcCtD
Indapamide—Loss of consciousness—Capecitabine—esophageal cancer	0.000216	0.00201	CcSEcCtD
Indapamide—Body temperature increased—Cisplatin—esophageal cancer	0.000215	0.002	CcSEcCtD
Indapamide—Cough—Capecitabine—esophageal cancer	0.000215	0.00199	CcSEcCtD
Indapamide—Hepatitis—Methotrexate—esophageal cancer	0.00021	0.00195	CcSEcCtD
Indapamide—Myalgia—Capecitabine—esophageal cancer	0.00021	0.00195	CcSEcCtD
Indapamide—Arthralgia—Capecitabine—esophageal cancer	0.00021	0.00195	CcSEcCtD
Indapamide—Chest pain—Capecitabine—esophageal cancer	0.00021	0.00195	CcSEcCtD
Indapamide—Pharyngitis—Methotrexate—esophageal cancer	0.000209	0.00194	CcSEcCtD
Indapamide—Anxiety—Capecitabine—esophageal cancer	0.000209	0.00194	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000208	0.00193	CcSEcCtD
Indapamide—Urinary tract disorder—Methotrexate—esophageal cancer	0.000208	0.00193	CcSEcCtD
Indapamide—Discomfort—Capecitabine—esophageal cancer	0.000207	0.00192	CcSEcCtD
Indapamide—Urethral disorder—Methotrexate—esophageal cancer	0.000206	0.00192	CcSEcCtD
Indapamide—Dry mouth—Capecitabine—esophageal cancer	0.000205	0.0019	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—esophageal cancer	0.000203	0.00188	CcSEcCtD
Indapamide—Oedema—Capecitabine—esophageal cancer	0.000201	0.00187	CcSEcCtD
Indapamide—Hypersensitivity—Cisplatin—esophageal cancer	0.000201	0.00186	CcSEcCtD
Indapamide—Infection—Capecitabine—esophageal cancer	0.0002	0.00185	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—esophageal cancer	0.000199	0.00185	CcSEcCtD
Indapamide—Shock—Capecitabine—esophageal cancer	0.000198	0.00184	CcSEcCtD
Indapamide—Nervous system disorder—Capecitabine—esophageal cancer	0.000197	0.00183	CcSEcCtD
Indapamide—Thrombocytopenia—Capecitabine—esophageal cancer	0.000197	0.00183	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—esophageal cancer	0.000196	0.00182	CcSEcCtD
Indapamide—Tachycardia—Capecitabine—esophageal cancer	0.000196	0.00182	CcSEcCtD
Indapamide—Asthenia—Cisplatin—esophageal cancer	0.000196	0.00182	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—esophageal cancer	0.000195	0.00181	CcSEcCtD
Indapamide—Skin disorder—Capecitabine—esophageal cancer	0.000195	0.00181	CcSEcCtD
Indapamide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000194	0.0018	CcSEcCtD
Indapamide—Anorexia—Capecitabine—esophageal cancer	0.000191	0.00178	CcSEcCtD
Indapamide—Hypotension—Capecitabine—esophageal cancer	0.000188	0.00174	CcSEcCtD
Indapamide—Diarrhoea—Cisplatin—esophageal cancer	0.000186	0.00173	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—esophageal cancer	0.000183	0.0017	CcSEcCtD
Indapamide—Erythema—Methotrexate—esophageal cancer	0.000183	0.0017	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000183	0.0017	CcSEcCtD
Indapamide—Insomnia—Capecitabine—esophageal cancer	0.000182	0.00169	CcSEcCtD
Indapamide—Paraesthesia—Capecitabine—esophageal cancer	0.00018	0.00168	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—esophageal cancer	0.000179	0.00167	CcSEcCtD
Indapamide—Dyspnoea—Capecitabine—esophageal cancer	0.000179	0.00166	CcSEcCtD
Indapamide—Back pain—Methotrexate—esophageal cancer	0.000177	0.00165	CcSEcCtD
Indapamide—Dyspepsia—Capecitabine—esophageal cancer	0.000177	0.00164	CcSEcCtD
Indapamide—Decreased appetite—Capecitabine—esophageal cancer	0.000175	0.00162	CcSEcCtD
Indapamide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000173	0.00161	CcSEcCtD
Indapamide—Vomiting—Cisplatin—esophageal cancer	0.000173	0.00161	CcSEcCtD
Indapamide—Fatigue—Capecitabine—esophageal cancer	0.000173	0.00161	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—esophageal cancer	0.000173	0.0016	CcSEcCtD
Indapamide—Rash—Cisplatin—esophageal cancer	0.000172	0.0016	CcSEcCtD
Indapamide—Pain—Capecitabine—esophageal cancer	0.000172	0.0016	CcSEcCtD
Indapamide—Constipation—Capecitabine—esophageal cancer	0.000172	0.0016	CcSEcCtD
Indapamide—Dermatitis—Cisplatin—esophageal cancer	0.000172	0.00159	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00017	0.00158	CcSEcCtD
Indapamide—Anaemia—Methotrexate—esophageal cancer	0.000169	0.00157	CcSEcCtD
Indapamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000166	0.00154	CcSEcCtD
Indapamide—Malaise—Methotrexate—esophageal cancer	0.000165	0.00153	CcSEcCtD
Indapamide—Vertigo—Methotrexate—esophageal cancer	0.000165	0.00153	CcSEcCtD
Indapamide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000164	0.00153	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—esophageal cancer	0.000164	0.00152	CcSEcCtD
Indapamide—Nausea—Cisplatin—esophageal cancer	0.000162	0.0015	CcSEcCtD
Indapamide—Cough—Methotrexate—esophageal cancer	0.00016	0.00148	CcSEcCtD
Indapamide—Urticaria—Capecitabine—esophageal cancer	0.00016	0.00148	CcSEcCtD
Indapamide—Abdominal pain—Capecitabine—esophageal cancer	0.000159	0.00147	CcSEcCtD
Indapamide—Body temperature increased—Capecitabine—esophageal cancer	0.000159	0.00147	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—esophageal cancer	0.000156	0.00145	CcSEcCtD
Indapamide—Chest pain—Methotrexate—esophageal cancer	0.000156	0.00145	CcSEcCtD
Indapamide—Myalgia—Methotrexate—esophageal cancer	0.000156	0.00145	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000155	0.00144	CcSEcCtD
Indapamide—Discomfort—Methotrexate—esophageal cancer	0.000154	0.00143	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—esophageal cancer	0.00015	0.00139	CcSEcCtD
Indapamide—Infection—Methotrexate—esophageal cancer	0.000149	0.00138	CcSEcCtD
Indapamide—Hypersensitivity—Capecitabine—esophageal cancer	0.000148	0.00137	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—esophageal cancer	0.000147	0.00136	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000146	0.00136	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—esophageal cancer	0.000145	0.00135	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—esophageal cancer	0.000145	0.00134	CcSEcCtD
Indapamide—Asthenia—Capecitabine—esophageal cancer	0.000144	0.00134	CcSEcCtD
Indapamide—Anorexia—Methotrexate—esophageal cancer	0.000143	0.00132	CcSEcCtD
Indapamide—Pruritus—Capecitabine—esophageal cancer	0.000142	0.00132	CcSEcCtD
Indapamide—Hypotension—Methotrexate—esophageal cancer	0.00014	0.0013	CcSEcCtD
Indapamide—Diarrhoea—Capecitabine—esophageal cancer	0.000137	0.00128	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000136	0.00127	CcSEcCtD
Indapamide—Insomnia—Methotrexate—esophageal cancer	0.000135	0.00126	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—esophageal cancer	0.000134	0.00125	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—esophageal cancer	0.000133	0.00124	CcSEcCtD
Indapamide—Somnolence—Methotrexate—esophageal cancer	0.000133	0.00123	CcSEcCtD
Indapamide—Dizziness—Capecitabine—esophageal cancer	0.000133	0.00123	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—esophageal cancer	0.000132	0.00122	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—esophageal cancer	0.00013	0.00121	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000129	0.0012	CcSEcCtD
Indapamide—Fatigue—Methotrexate—esophageal cancer	0.000129	0.0012	CcSEcCtD
Indapamide—Pain—Methotrexate—esophageal cancer	0.000128	0.00119	CcSEcCtD
Indapamide—Vomiting—Capecitabine—esophageal cancer	0.000128	0.00119	CcSEcCtD
Indapamide—Rash—Capecitabine—esophageal cancer	0.000127	0.00118	CcSEcCtD
Indapamide—Dermatitis—Capecitabine—esophageal cancer	0.000127	0.00118	CcSEcCtD
Indapamide—Headache—Capecitabine—esophageal cancer	0.000126	0.00117	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—esophageal cancer	0.000123	0.00114	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000122	0.00114	CcSEcCtD
Indapamide—Nausea—Capecitabine—esophageal cancer	0.000119	0.00111	CcSEcCtD
Indapamide—Urticaria—Methotrexate—esophageal cancer	0.000119	0.0011	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—esophageal cancer	0.000118	0.0011	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—esophageal cancer	0.000118	0.0011	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—esophageal cancer	0.00011	0.00102	CcSEcCtD
Indapamide—Asthenia—Methotrexate—esophageal cancer	0.000107	0.000996	CcSEcCtD
Indapamide—CA5A—Metabolism—TPI1—esophageal cancer	0.000106	0.000709	CbGpPWpGaD
Indapamide—Pruritus—Methotrexate—esophageal cancer	0.000106	0.000982	CcSEcCtD
Indapamide—CA4—Metabolism—CA2—esophageal cancer	0.000104	0.000694	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALOX15—esophageal cancer	0.000104	0.000694	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALOX15—esophageal cancer	0.000104	0.000694	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000104	0.000693	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000104	0.00069	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000102	0.000683	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—HIF1A—esophageal cancer	0.000102	0.000683	CbGpPWpGaD
Indapamide—Diarrhoea—Methotrexate—esophageal cancer	0.000102	0.00095	CcSEcCtD
Indapamide—CA5A—Metabolism—ALDOB—esophageal cancer	0.000102	0.00068	CbGpPWpGaD
Indapamide—CA12—Metabolism—TYMP—esophageal cancer	0.000102	0.000678	CbGpPWpGaD
Indapamide—CA7—Metabolism—TPI1—esophageal cancer	9.93e-05	0.000662	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TPI1—esophageal cancer	9.93e-05	0.000662	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTO1—esophageal cancer	9.93e-05	0.000662	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTO1—esophageal cancer	9.93e-05	0.000662	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP26A1—esophageal cancer	9.89e-05	0.00066	CbGpPWpGaD
Indapamide—Dizziness—Methotrexate—esophageal cancer	9.89e-05	0.000918	CcSEcCtD
Indapamide—CA5A—Metabolism—GAPDH—esophageal cancer	9.81e-05	0.000654	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	9.73e-05	0.000649	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CRABP1—esophageal cancer	9.73e-05	0.000649	CbGpPWpGaD
Indapamide—CA4—Metabolism—PLCE1—esophageal cancer	9.68e-05	0.000645	CbGpPWpGaD
Indapamide—CA4—Metabolism—ADH7—esophageal cancer	9.68e-05	0.000645	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALOX15—esophageal cancer	9.64e-05	0.000643	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.62e-05	0.000642	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALDOB—esophageal cancer	9.52e-05	0.000635	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALDOB—esophageal cancer	9.52e-05	0.000635	CbGpPWpGaD
Indapamide—Vomiting—Methotrexate—esophageal cancer	9.51e-05	0.000883	CcSEcCtD
Indapamide—Rash—Methotrexate—esophageal cancer	9.43e-05	0.000876	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—esophageal cancer	9.42e-05	0.000875	CcSEcCtD
Indapamide—Headache—Methotrexate—esophageal cancer	9.37e-05	0.00087	CcSEcCtD
Indapamide—CA2—Metabolism—ADH7—esophageal cancer	9.28e-05	0.000619	CbGpPWpGaD
Indapamide—CA2—Metabolism—PLCE1—esophageal cancer	9.28e-05	0.000619	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GNG7—esophageal cancer	9.25e-05	0.000617	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	9.24e-05	0.000616	CbGpPWpGaD
Indapamide—CA9—Metabolism—CA1—esophageal cancer	9.2e-05	0.000613	CbGpPWpGaD
Indapamide—CA12—Metabolism—TPI1—esophageal cancer	9.2e-05	0.000613	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC10A2—esophageal cancer	9.2e-05	0.000613	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTO1—esophageal cancer	9.2e-05	0.000613	CbGpPWpGaD
Indapamide—CA7—Metabolism—GAPDH—esophageal cancer	9.16e-05	0.000611	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GAPDH—esophageal cancer	9.16e-05	0.000611	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CRABP1—esophageal cancer	9.08e-05	0.000606	CbGpPWpGaD
Indapamide—CA7—Metabolism—CRABP1—esophageal cancer	9.08e-05	0.000606	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	8.95e-05	0.000597	CbGpPWpGaD
Indapamide—Nausea—Methotrexate—esophageal cancer	8.88e-05	0.000825	CcSEcCtD
Indapamide—CA12—Metabolism—ALDOB—esophageal cancer	8.82e-05	0.000588	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ALDH2—esophageal cancer	8.67e-05	0.000578	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GNG7—esophageal cancer	8.64e-05	0.000576	CbGpPWpGaD
Indapamide—CA7—Metabolism—GNG7—esophageal cancer	8.64e-05	0.000576	CbGpPWpGaD
Indapamide—CA12—Metabolism—GAPDH—esophageal cancer	8.49e-05	0.000566	CbGpPWpGaD
Indapamide—CA4—Metabolism—ADH1B—esophageal cancer	8.49e-05	0.000566	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	8.42e-05	0.000561	CbGpPWpGaD
Indapamide—CA9—Metabolism—CA2—esophageal cancer	8.41e-05	0.000561	CbGpPWpGaD
Indapamide—CA12—Metabolism—CRABP1—esophageal cancer	8.41e-05	0.000561	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	8.37e-05	0.000558	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CREBBP—esophageal cancer	8.36e-05	0.000558	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—RB1—esophageal cancer	8.33e-05	0.000556	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	8.26e-05	0.000551	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTT1—esophageal cancer	8.25e-05	0.00055	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP2A6—esophageal cancer	8.15e-05	0.000544	CbGpPWpGaD
Indapamide—CA2—Metabolism—ADH1B—esophageal cancer	8.14e-05	0.000543	CbGpPWpGaD
Indapamide—CA4—Metabolism—TYMP—esophageal cancer	8.11e-05	0.000541	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALDH2—esophageal cancer	8.09e-05	0.00054	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALDH2—esophageal cancer	8.09e-05	0.00054	CbGpPWpGaD
Indapamide—CA12—Metabolism—GNG7—esophageal cancer	8e-05	0.000534	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	7.98e-05	0.000532	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP26A1—esophageal cancer	7.89e-05	0.000526	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	7.87e-05	0.000525	CbGpPWpGaD
Indapamide—CA9—Metabolism—PLCE1—esophageal cancer	7.82e-05	0.000522	CbGpPWpGaD
Indapamide—CA9—Metabolism—ADH7—esophageal cancer	7.82e-05	0.000522	CbGpPWpGaD
Indapamide—CA2—Metabolism—TYMP—esophageal cancer	7.78e-05	0.000519	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	7.77e-05	0.000518	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS1—esophageal cancer	7.73e-05	0.000515	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ENO1—esophageal cancer	7.73e-05	0.000515	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—ADH7—esophageal cancer	7.7e-05	0.000513	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTT1—esophageal cancer	7.7e-05	0.000513	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTT1—esophageal cancer	7.7e-05	0.000513	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALOX15—esophageal cancer	7.69e-05	0.000513	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PSME2—esophageal cancer	7.61e-05	0.000508	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PSME1—esophageal cancer	7.61e-05	0.000508	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP2A6—esophageal cancer	7.61e-05	0.000507	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP2A6—esophageal cancer	7.61e-05	0.000507	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP26A1—esophageal cancer	7.56e-05	0.000504	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALDH2—esophageal cancer	7.5e-05	0.0005	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALOX15—esophageal cancer	7.37e-05	0.000492	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTO1—esophageal cancer	7.34e-05	0.000489	CbGpPWpGaD
Indapamide—CA4—Metabolism—TPI1—esophageal cancer	7.34e-05	0.000489	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN2A—esophageal cancer	7.33e-05	0.000489	CbGpPWpGaD
Indapamide—CA7—Metabolism—ENO1—esophageal cancer	7.21e-05	0.000481	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ENO1—esophageal cancer	7.21e-05	0.000481	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS1—esophageal cancer	7.21e-05	0.000481	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS1—esophageal cancer	7.21e-05	0.000481	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTT1—esophageal cancer	7.13e-05	0.000476	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PSME2—esophageal cancer	7.11e-05	0.000474	CbGpPWpGaD
Indapamide—CA7—Metabolism—PSME2—esophageal cancer	7.11e-05	0.000474	CbGpPWpGaD
Indapamide—CA7—Metabolism—PSME1—esophageal cancer	7.11e-05	0.000474	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PSME1—esophageal cancer	7.11e-05	0.000474	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP2A6—esophageal cancer	7.05e-05	0.00047	CbGpPWpGaD
Indapamide—CA2—Metabolism—TPI1—esophageal cancer	7.03e-05	0.000469	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTO1—esophageal cancer	7.03e-05	0.000469	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALDOB—esophageal cancer	7.03e-05	0.000469	CbGpPWpGaD
Indapamide—CA9—Metabolism—ADH1B—esophageal cancer	6.86e-05	0.000457	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	6.79e-05	0.000453	CbGpPWpGaD
Indapamide—CA4—Metabolism—GAPDH—esophageal cancer	6.77e-05	0.000451	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	6.75e-05	0.00045	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALDOB—esophageal cancer	6.74e-05	0.00045	CbGpPWpGaD
Indapamide—CA4—Metabolism—CRABP1—esophageal cancer	6.71e-05	0.000447	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS1—esophageal cancer	6.68e-05	0.000446	CbGpPWpGaD
Indapamide—CA12—Metabolism—ENO1—esophageal cancer	6.68e-05	0.000446	CbGpPWpGaD
Indapamide—CA12—Metabolism—PSME2—esophageal cancer	6.59e-05	0.000439	CbGpPWpGaD
Indapamide—CA12—Metabolism—PSME1—esophageal cancer	6.59e-05	0.000439	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP1B1—esophageal cancer	6.57e-05	0.000438	CbGpPWpGaD
Indapamide—CA9—Metabolism—TYMP—esophageal cancer	6.55e-05	0.000437	CbGpPWpGaD
Indapamide—CA2—Metabolism—GAPDH—esophageal cancer	6.49e-05	0.000433	CbGpPWpGaD
Indapamide—CA2—Metabolism—CRABP1—esophageal cancer	6.43e-05	0.000429	CbGpPWpGaD
Indapamide—CA4—Metabolism—GNG7—esophageal cancer	6.38e-05	0.000426	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	6.38e-05	0.000425	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP26A1—esophageal cancer	6.38e-05	0.000425	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	6.28e-05	0.000419	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALOX15—esophageal cancer	6.21e-05	0.000414	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	6.19e-05	0.000413	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP19A1—esophageal cancer	6.18e-05	0.000412	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.17e-05	0.000412	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP1B1—esophageal cancer	6.13e-05	0.000409	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP1B1—esophageal cancer	6.13e-05	0.000409	CbGpPWpGaD
Indapamide—CA2—Metabolism—GNG7—esophageal cancer	6.12e-05	0.000408	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN1A—esophageal cancer	5.99e-05	0.000399	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALDH2—esophageal cancer	5.98e-05	0.000399	CbGpPWpGaD
Indapamide—CA9—Metabolism—TPI1—esophageal cancer	5.93e-05	0.000395	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTO1—esophageal cancer	5.93e-05	0.000395	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	5.83e-05	0.000389	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP19A1—esophageal cancer	5.77e-05	0.000385	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP19A1—esophageal cancer	5.77e-05	0.000385	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	5.75e-05	0.000384	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALDH2—esophageal cancer	5.73e-05	0.000382	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—EP300—esophageal cancer	5.7e-05	0.00038	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTT1—esophageal cancer	5.69e-05	0.000379	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALDOB—esophageal cancer	5.68e-05	0.000379	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1B1—esophageal cancer	5.68e-05	0.000379	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HMOX1—esophageal cancer	5.64e-05	0.000376	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP2A6—esophageal cancer	5.62e-05	0.000375	CbGpPWpGaD
Indapamide—CA9—Metabolism—GAPDH—esophageal cancer	5.47e-05	0.000365	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTT1—esophageal cancer	5.45e-05	0.000364	CbGpPWpGaD
Indapamide—CA9—Metabolism—CRABP1—esophageal cancer	5.42e-05	0.000362	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ABCB1—esophageal cancer	5.41e-05	0.000361	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP2A6—esophageal cancer	5.39e-05	0.000359	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP19A1—esophageal cancer	5.34e-05	0.000356	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS1—esophageal cancer	5.33e-05	0.000355	CbGpPWpGaD
Indapamide—CA4—Metabolism—ENO1—esophageal cancer	5.33e-05	0.000355	CbGpPWpGaD
Indapamide—CA7—Metabolism—HMOX1—esophageal cancer	5.26e-05	0.000351	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HMOX1—esophageal cancer	5.26e-05	0.000351	CbGpPWpGaD
Indapamide—CA4—Metabolism—PSME1—esophageal cancer	5.25e-05	0.00035	CbGpPWpGaD
Indapamide—CA4—Metabolism—PSME2—esophageal cancer	5.25e-05	0.00035	CbGpPWpGaD
Indapamide—CA9—Metabolism—GNG7—esophageal cancer	5.16e-05	0.000344	CbGpPWpGaD
Indapamide—CA2—Metabolism—ENO1—esophageal cancer	5.11e-05	0.000341	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS1—esophageal cancer	5.11e-05	0.000341	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ABCB1—esophageal cancer	5.05e-05	0.000337	CbGpPWpGaD
Indapamide—CA7—Metabolism—ABCB1—esophageal cancer	5.05e-05	0.000337	CbGpPWpGaD
Indapamide—CA2—Metabolism—PSME2—esophageal cancer	5.03e-05	0.000336	CbGpPWpGaD
Indapamide—CA2—Metabolism—PSME1—esophageal cancer	5.03e-05	0.000336	CbGpPWpGaD
Indapamide—CA12—Metabolism—HMOX1—esophageal cancer	4.88e-05	0.000325	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALDH2—esophageal cancer	4.83e-05	0.000322	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	4.76e-05	0.000317	CbGpPWpGaD
Indapamide—CA12—Metabolism—ABCB1—esophageal cancer	4.68e-05	0.000312	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTT1—esophageal cancer	4.6e-05	0.000306	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP2A6—esophageal cancer	4.54e-05	0.000303	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1B1—esophageal cancer	4.53e-05	0.000302	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	4.52e-05	0.000302	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	4.47e-05	0.000298	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1B1—esophageal cancer	4.34e-05	0.00029	CbGpPWpGaD
Indapamide—CA9—Metabolism—ENO1—esophageal cancer	4.31e-05	0.000287	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS1—esophageal cancer	4.31e-05	0.000287	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP19A1—esophageal cancer	4.26e-05	0.000284	CbGpPWpGaD
Indapamide—CA9—Metabolism—PSME2—esophageal cancer	4.24e-05	0.000283	CbGpPWpGaD
Indapamide—CA9—Metabolism—PSME1—esophageal cancer	4.24e-05	0.000283	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	4.24e-05	0.000283	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP19A1—esophageal cancer	4.08e-05	0.000272	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—esophageal cancer	4.08e-05	0.000272	CbGpPWpGaD
Indapamide—CA4—Metabolism—HMOX1—esophageal cancer	3.89e-05	0.000259	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCB1—esophageal cancer	3.73e-05	0.000249	CbGpPWpGaD
Indapamide—CA2—Metabolism—HMOX1—esophageal cancer	3.73e-05	0.000249	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1B1—esophageal cancer	3.66e-05	0.000244	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CREBBP—esophageal cancer	3.62e-05	0.000241	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	3.6e-05	0.00024	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCB1—esophageal cancer	3.58e-05	0.000239	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	3.56e-05	0.000237	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP19A1—esophageal cancer	3.44e-05	0.00023	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	3.39e-05	0.000226	CbGpPWpGaD
Indapamide—CA7—Metabolism—CREBBP—esophageal cancer	3.38e-05	0.000225	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CREBBP—esophageal cancer	3.38e-05	0.000225	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	3.34e-05	0.000223	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NOS3—esophageal cancer	3.24e-05	0.000216	CbGpPWpGaD
Indapamide—CA9—Metabolism—HMOX1—esophageal cancer	3.14e-05	0.00021	CbGpPWpGaD
Indapamide—CA12—Metabolism—CREBBP—esophageal cancer	3.13e-05	0.000209	CbGpPWpGaD
Indapamide—CA7—Metabolism—NOS3—esophageal cancer	3.02e-05	0.000202	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NOS3—esophageal cancer	3.02e-05	0.000202	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCB1—esophageal cancer	3.02e-05	0.000201	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—esophageal cancer	2.96e-05	0.000197	CbGpPWpGaD
Indapamide—CA12—Metabolism—NOS3—esophageal cancer	2.8e-05	0.000187	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—esophageal cancer	2.76e-05	0.000184	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—esophageal cancer	2.76e-05	0.000184	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—esophageal cancer	2.56e-05	0.000171	CbGpPWpGaD
Indapamide—CA4—Metabolism—CREBBP—esophageal cancer	2.49e-05	0.000166	CbGpPWpGaD
Indapamide—CA5A—Metabolism—EP300—esophageal cancer	2.46e-05	0.000164	CbGpPWpGaD
Indapamide—CA2—Metabolism—CREBBP—esophageal cancer	2.39e-05	0.000159	CbGpPWpGaD
Indapamide—CA5B—Metabolism—EP300—esophageal cancer	2.3e-05	0.000153	CbGpPWpGaD
Indapamide—CA7—Metabolism—EP300—esophageal cancer	2.3e-05	0.000153	CbGpPWpGaD
Indapamide—CA4—Metabolism—NOS3—esophageal cancer	2.23e-05	0.000149	CbGpPWpGaD
Indapamide—CA2—Metabolism—NOS3—esophageal cancer	2.14e-05	0.000143	CbGpPWpGaD
Indapamide—CA12—Metabolism—EP300—esophageal cancer	2.13e-05	0.000142	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—esophageal cancer	2.04e-05	0.000136	CbGpPWpGaD
Indapamide—CA9—Metabolism—CREBBP—esophageal cancer	2.02e-05	0.000134	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—esophageal cancer	1.96e-05	0.000131	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—esophageal cancer	1.82e-05	0.000121	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.82e-05	0.000121	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.82e-05	0.000121	CbGpPWpGaD
Indapamide—CA9—Metabolism—NOS3—esophageal cancer	1.8e-05	0.00012	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—esophageal cancer	1.7e-05	0.000113	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—esophageal cancer	1.7e-05	0.000113	CbGpPWpGaD
Indapamide—CA4—Metabolism—EP300—esophageal cancer	1.7e-05	0.000113	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—esophageal cancer	1.65e-05	0.00011	CbGpPWpGaD
Indapamide—CA2—Metabolism—EP300—esophageal cancer	1.63e-05	0.000109	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—esophageal cancer	1.58e-05	0.000105	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.55e-05	0.000103	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA1—esophageal cancer	1.55e-05	0.000103	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA2—esophageal cancer	1.42e-05	9.44e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—EP300—esophageal cancer	1.37e-05	9.15e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.32e-05	8.78e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADH7—esophageal cancer	1.32e-05	8.78e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—esophageal cancer	1.26e-05	8.38e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—esophageal cancer	1.2e-05	8.03e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.15e-05	7.7e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TYMP—esophageal cancer	1.1e-05	7.36e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.07e-05	7.16e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.05e-05	6.97e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—esophageal cancer	1.02e-05	6.77e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.98e-06	6.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TPI1—esophageal cancer	9.98e-06	6.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	9.57e-06	6.38e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	9.21e-06	6.14e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	9.13e-06	6.09e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GNG7—esophageal cancer	8.68e-06	5.79e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.13e-06	5.42e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.74e-06	5.16e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.65e-06	5.1e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ENO1—esophageal cancer	7.25e-06	4.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.25e-06	4.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PSME1—esophageal cancer	7.14e-06	4.76e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PSME2—esophageal cancer	7.14e-06	4.76e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.16e-06	4.11e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.8e-06	3.86e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.29e-06	3.53e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.08e-06	3.39e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.39e-06	2.26e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NOS3—esophageal cancer	3.04e-06	2.03e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.78e-06	1.85e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—EP300—esophageal cancer	2.31e-06	1.54e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.71e-06	1.14e-05	CbGpPWpGaD
